Sort
261,768 grants matching “gene therapy”
ONCOGENES IN CANCER ETIOLOGY AND PROGRESSION
$1,085,565Thomas Jefferson University · P01 · FY2001 · CA
Probing Systems-Level Function of Fronto-Temporal
$1,085,531Jack M. Gorman · New York University · P50 · FY2007 · MH
Signal Transduction Events and the Regulation of Cell Growth
$1,085,526Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2023 · CA
Mechanisms of inherited neurodegenerative diseases
$1,085,466Michael Ward · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Extended half-life GlyTR1 combined with checkpoint blockade for Cancer Immunotherapy
$1,085,460Michael Demetriou · Glytr Therapeutics, Inc. · R42 · FY2025 · CA
Bio-Therapies for the Treatment of Cancer
$1,085,439David Fitzgerald · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
North American Mitochondrial Disease Consortium (NAMDC)
$1,085,410Michio Hirano · Columbia University Health Sciences · U54 · FY2013 · NS
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,085,319Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Drug resistance enablers and their role in antibiotic treatment failure
$1,085,284Vaughn Cooper · Boston Children'S Hospital · U19 · FY2024 · AI
Allogeneic Hematopoietic Transplantation for Primary Immunodeficiency Diseases
$1,085,274Dennis Hickstein · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Asthma and Allergic Diseases Cooperative Research Center
$1,085,267Yong-Jun Liu · University Of Tx Md Anderson Can Ctr · U19 · FY2008 · AI
Depletion, Repopulation and Tolerance in Sensitized Recipients
$1,085,214Stuart Johnston Knechtle · Duke University · U19 · FY2017 · AI
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,085,210Aaron D. Gitler · Stanford University · R35 · FY2024 · NS
Organization and development of the S-cone system
$1,085,205Wei Li · National Eye Institute · ZIA · FY2022 · EY
Long-Term Neural Determinants of Cardiovascular Diseases
$1,085,178John W Osborn · University Of Minnesota · R01 · FY2007 · HL
UCSF Project 1
$1,085,090Trever G Bivona · University Of California, San Francisco · U54 · FY2017 · CA
NADPH Oxidases as Novel Targets for Cancer Therapy
$1,084,950James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)
$1,084,905David H Haussler · University Of California Santa Cruz · U24 · FY2010 · CA
Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision
$1,084,866Hui Zhang · Johns Hopkins University · U24 · FY2024 · CA
Nonhuman Primate Core
$1,084,797Shiu-Lok Hu · Fred Hutchinson Cancer Research Center · U19 · FY2011 · AI
Leber Hereditary Optic Neuropathy: Gene Therapy Trial
$1,084,780John R Guy · University Of Miami School Of Medicine · R24 · FY2011 · EY
Genetically Engineered Mouse Models to Study RTK Function in Melanoma
$1,084,624Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Transgenic animal production for neuroscience research
$1,084,591James Pickel · National Institute Of Mental Health · Z01 · FY2007 · MH
Understanding mechanisms and seeking novel biomarkers in Alzheimer's disease
$1,084,419Madhav Thambisetty · National Institute On Aging · ZIA · FY2015 · AG
Determinants of donor-specific T cell tolerance in kidney transplantation in non-sensitized recipients
$1,084,414Xunrong Luo · Duke University · U19 · FY2025 · AI